Methods of treating bone-loss disorders using a GM-CSF antagonist

Details for Australian Patent Application No. 2009206082 (hide)

Owner KaloBios Pharmaceuticals, Inc.

Inventors Yarranton, Geoffrey T.; Bebbington, Christopher R.

Agent Pizzeys

Pub. Number AU-A-2009206082

PCT Pub. Number WO2009/091905

Priority 61/021,218 15.01.08 US

Filing date 15 January 2009

Wipo publication date 23 July 2009

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/091905 Priority application(s): WO2009/091905

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009206089-Improved mammalian expression vectors and uses thereof

2009206075-6-and 7-amino isoquinoline compounds and methods for making and using the same